Oliver Hartley
Company: Orion Biotechnology
Job title: Vice President, Drug discovery
Seminars:
Advancing the Optimization of Lead Biologic Candidates using New Screening Platforms 2:10 pm
What is the workflow to screening for highly specific biologics How to enhance binding affinity of anti-GPCR antibodies with chemical optimization? How to exploit the druggability of antibodies to target previously undrugged GPCRs?Read more
day: Day One Track B PM
Discovering the Next-Generation of GPCR-targeted Therapeutics to Address Metabolic Diseases with Unmet Patient Needs 10:00 am
Leveraging a novel drug modality and proprietary discovery platform to unlock peptide & protein GPCRs Advancing a pipeline of differentiated therapeutics for cardiometabolic and immunological diseases Capturing the untapped potential of Class A and Class B GPCRs with novel therapeutic approaches and drug-conjugates Read more
day: Day Two AM
TRACK B: Hit ID & Optimization 10:35 am
day: Day One Track B AM
Chair’s Opening Remarks 8:50 am
day: Day One AM